HIV
Researchers from the University of Miami have made significant progress in the development of a new approach for preventing and treating HIV infection. The study, published in Nature Communications, presented a promising method of using adeno-associated virus (AAV) vector to deliver broadly neutralizing antibodies (bnAbs) for long-term HIV prevention and
HIV
Research conducted across 31 provincial-level administrative divisions in China between April and June 2023 has found that transmitted drug resistance (TDR) among individuals newly diagnosed with HIV-1 in China exceeds 10%. The study analyzed demographic information and blood samples from 6,654 participants and found that TDR prevalence was 11.
HIV
Researchers at the University of Campania 'Luigi Vanvitelli' in Naples, Italy, have made a significant breakthrough in HIV/AIDS treatment by exploring new combination therapies. Despite the progress of antiretroviral therapy, some patients with multidrug-resistant (MDR) HIV infection continue to struggle with the disease. The study investigated the
HIV
Research conducted in Guangxi, China, from 2019 to 2022 has revealed a significant problem with pretreatment drug resistance (PDR) in HIV/AIDS therapy. The study, led by researchers from Guangxi Medical University, found that the overall prevalence of PDR was 8.4% among newly diagnosed, antiretroviral therapy (ART)-naive individuals.
HIV
Researchers at the University of Douala in Cameroon have identified a high level of HIV-1 drug resistance mutations among adolescents with detectable viremia. The study, published in the Journal of Antimicrobial Chemotherapy, analyzed 127 plasma and paired buffy-coat samples collected from 90 adolescents between February and September 2021. The findings
HIV
In a landmark study conducted at the Mildmay-Uganda Hospital from 2018 to 2023, researchers analyzed data from 235 people living with HIV (PLHIV) and found that early drug resistance mutations testing and individualized antiretroviral therapy (ART) can significantly improve HIV treatment outcomes. The study, led by Collins Ankunda and colleagues,
HIV
Research conducted at Fudan University in Shanghai, China, has shed light on the differences in pulmonary microbiota between HIV-positive and HIV-negative patients with pneumocystis jirovecii infection. The study, published in PLOS ONE, aimed to investigate the alterations in the pulmonary microbiota of HIV-positive and non-HIV patients following pneumocystis jirovecii infection.
HIV
Researchers at Michigan State University have shed light on the complexities of immune system diseases and conditions, specifically HIV/AIDS. A recent case study highlights the challenge of diagnosing myopericarditis, a condition that can masquerade as a heart attack in people living with HIV. The study's findings emphasize
HIV
A new report from researchers at Kampala International University in Uganda reveals that vitamin B12 deficiency is a common comorbidity among HIV-infected individuals, contributing to anemia, neurological impairment, and poor immune recovery. The study, conducted at Kayunga Regional Referral Hospital, found that vitamin B12 deficiency was prevalent among HIV-positive adults
HIV
Researchers at the University of Lyon have made a groundbreaking discovery in the fight against HIV/AIDS. The team found that the innate immune factor Trim69 can remodel microtubules, inhibiting the docking and migration of HIV virion cores on microtubules. This finding sheds light on a novel mechanism of viral
HIV
Research has shed light on the complexities surrounding the HIV care continuum, highlighting multiple barriers that hinder retention in care, including structural, systemic, and individual factors. A recent study conducted at the NOVA Southeastern University examined individuals living with HIV (PLH) who had detectable HIV-1 viral loads, with the goal
HIV
A case study from the Tianjin Centers for Disease Control and Prevention in China has revealed that improper use of pre-exposure prophylaxis (PrEP) can lead to breakthrough infections and diagnostic challenges. Despite the high efficacy of PrEP in preventing HIV infection among men who have sex with men (MSM), the
